BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7741015)

  • 21. Protein tyrosine nitration in hyperammonemia and hepatic encephalopathy.
    Häussinger D; Görg B; Reinehr R; Schliess F
    Metab Brain Dis; 2005 Dec; 20(4):285-94. PubMed ID: 16382339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear magnetic resonance studies of energy metabolism and glutamine shunt in hepatic encephalopathy and hyperammonemia.
    Zwingmann C
    J Neurosci Res; 2007 Nov; 85(15):3429-42. PubMed ID: 17722064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ammonia neurotoxicity and the mitochondrial permeability transition.
    Norenberg MD; Rama Rao KV; Jayakumar AR
    J Bioenerg Biomembr; 2004 Aug; 36(4):303-7. PubMed ID: 15377862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal and glial marker proteins in encephalopathy associated with acute liver failure and acute hyperammonemia in the rabbit.
    Groeneweg M; de Knegt RJ; Hamberger A; Ding M; Wang S; Schalm SW; Haglid KG
    Metab Brain Dis; 1993 Jun; 8(2):95-106. PubMed ID: 8355642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astrocyte dysfunction in neurological disorders: a molecular perspective.
    Seifert G; Schilling K; Steinhäuser C
    Nat Rev Neurosci; 2006 Mar; 7(3):194-206. PubMed ID: 16495941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osmotic and oxidative/nitrosative stress in ammonia toxicity and hepatic encephalopathy.
    Görg B; Schliess F; Häussinger D
    Arch Biochem Biophys; 2013 Aug; 536(2):158-63. PubMed ID: 23567841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease.
    Hadjihambi A; De Chiara F; Hosford PS; Habtetion A; Karagiannis A; Davies N; Gourine AV; Jalan R
    Hepatology; 2017 Apr; 65(4):1306-1318. PubMed ID: 28066916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ammonia toxicity under hyponatremic conditions in astrocytes: de novo synthesis of amino acids for the osmoregulatory response.
    Zwingmann C; Leibfritz D
    Neurochem Int; 2005 Jul; 47(1-2):39-50. PubMed ID: 15908044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatogenic hyperammonemia].
    Pichon R
    Maroc Med; 1972 Jan; 52(553):34-6. PubMed ID: 5039647
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices.
    Reinehr R; Görg B; Becker S; Qvartskhava N; Bidmon HJ; Selbach O; Haas HL; Schliess F; Häussinger D
    Glia; 2007 May; 55(7):758-71. PubMed ID: 17352382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic encephalopathy, hyperammonemia, and ammonia toxicity. Papers presented at the International Symposium on Cirrhosis, Hyperammonemia and hepatic encephalopathy. Valencia, Spain, January 24-27, 1994.
    Adv Exp Med Biol; 1994; 368():1-205. PubMed ID: 7740999
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of NH
    Bartolić M; Vovk A; Šuput D
    Cell Mol Biol Lett; 2016; 21():13. PubMed ID: 28536616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible implication of ciliary neurotrophic factor (CNTF) and beta-synuclein in the ammonia effect on cultured rat astroglial cells: a study using DNA and protein microarrays.
    Bodega G; Suárez I; López-Fernández LA; Almonacid L; Zaballos A; Fernández B
    Neurochem Int; 2006 Jun; 48(8):729-38. PubMed ID: 16483693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation.
    Shawcross D; Jalan R
    Cell Mol Life Sci; 2005 Oct; 62(19-20):2295-304. PubMed ID: 16158192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.
    Kristiansen RG
    Metab Brain Dis; 2016 Dec; 31(6):1357-1358. PubMed ID: 27651377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothesis: A molecular basis for the hyperammonemia and potassium wastage associated with hepatic failure.
    Zweig JI
    Mt Sinai J Med; 1976; 43(2):109-21. PubMed ID: 1082976
    [No Abstract]   [Full Text] [Related]  

  • 37. Brain metabolism in patients with hepatic encephalopathy studied by PET and MR.
    Keiding S; Pavese N
    Arch Biochem Biophys; 2013 Aug; 536(2):131-42. PubMed ID: 23726863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of Kir4.1 in the cerebral cortex of rats with liver failure and in cultured astrocytes treated with glutamine: Implications for astrocytic dysfunction in hepatic encephalopathy.
    Obara-Michlewska M; Pannicke T; Karl A; Bringmann A; Reichenbach A; Szeliga M; Hilgier W; Wrzosek A; Szewczyk A; Albrecht J
    J Neurosci Res; 2011 Dec; 89(12):2018-27. PubMed ID: 21538466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ammonia, glutamine, and serum on calcineurin, p38MAPK-diP, GADD153/CHOP10, and CNTF in primary rat astrocyte cultures.
    Bodega G; Suárez I; Paniagua C; Vacas E; Fernández B
    Brain Res; 2007 Oct; 1175():126-33. PubMed ID: 17888887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperammonemia compromises glutamate metabolism and reduces BDNF in the rat hippocampus.
    Galland F; Negri E; Da Ré C; Fróes F; Strapazzon L; Guerra MC; Tortorelli LS; Gonçalves CA; Leite MC
    Neurotoxicology; 2017 Sep; 62():46-55. PubMed ID: 28506823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.